Event Brief
Jun 9, 2026 at 4:02 AM ET
GSK buys Nuvalent in $10.6B deal to bolster cancer portfolio
By The BriefBrief
GSK agreed to buy U.S.-listed biotech Nuvalent for $10.6 billion, its biggest acquisition in eight years.
WHO: GSK
WHAT: GSK struck a $10.6 billion deal to buy Nuvalent
WHEN: Jun 9, 2026 at 3:37 AM ET
WHERE: Location not specified
WHY: To bolster the cancer portfolio it had previously trimmed
Reporting from 2 identified publishers across this event arc.
View all 2 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
White House warns UK against under-16 social media ban
Europe
Jun 9, 2026 at 4:04 AM ET
Knicks fans fly worldwide to attend games in NYC
Knicks
Jun 9, 2026 at 4:04 AM ET
Trump tells BBC Netanyahu did not defy him
Donald Trump
Jun 9, 2026 at 4:04 AM ET
Man taken to hospital after Belfast stabbing
Belfast
Jun 9, 2026 at 4:04 AM ET
Page 16167 of 21461
Same format. Every time.
Continue reading — sign in or create a free account with
